Chicago, IL – July 27, 2010 - Panthera Global, Inc. (“PGI”) is pleased to announce that it has formed a strategic partnership with LifeTech Research, Inc. to collaborate on providing transactional advisory services to companies across the life sciences sector.  Main sectors of focus include biotechnology, biopharmaceuticals, specialty pharmaceuticals, drug delivery systems and medical devices. 

“We are pleased to announce this partnership with LifeTech” stated Larry Carter of Panthera Global, Inc.  "LifeTech’s experienced team with strong clinical, regulatory and policy insights will certainly be an asset to the partnership and will enable PGI to execute transactions more efficiently and effectively for clients within the life sciences sector.”

”We welcome the opportunity to work with Panthera’s clients in a manner that will optimally position them for future financings, value creation through smart technology development and commercialization and transformative business development relationships” stated Dr. Joel Braunstein of LifeTech Research. 

LifeTech Research, Inc. is a unique provider of investment due diligence research and business development services across the entire life sciences sector.  Founded in 2003, LifeTech advises institutional investors and business development officers on product investment, licensing and acquisition strategies. The company also assists entrepreneurs with disruptive ideas and technologies that have the potential to create new standards within healthcare.